![Daniel Tassé](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Tassé
Chief Executive Officer at
DBV TECHNOLOGIES
Net worth: 202 316 $ as of 31/05/2026
Profile
Daniel Tassé is Chief Executive Officer & Director at DBV Technologies SA since 2019, Director at BioQ Pharma, Inc. since 2014, Lead Independent Non-Executive Director at REGENXBIO, Inc. since 2024, and Director at Roundtable On Critical Care Policy.
Former roles include Chairman, President & Chief Executive Officer at Ikaria, Inc. from 2009 to 2015; Chairman & Chief Executive Officer at Alcresta Therapeutics, Inc. from 2016 to 2018; Director at Biotechnology Innovation Organization from 2011 to 2015; Director at Bellerophon Therapeutics, Inc. from 2014 to 2019; Senior Independent Director at Indivior Ltd. from 2020 to 2021; Vice President & Regional Director-Australasia at GSK Plc in 2004; Director at Pharmaceutical Research & Manufacturers of America from 2011 to 2015; Independent Director at HLS Therapeutics, Inc. from 2018 to 2019; GM-Pharmaceuticals & Technologies Business Unit at Baxter International, Inc. in 2008; Member at Healthcare Leadership Council; and Chief Financial Officer at NRG Energy Ltd. Education includes undergraduate studies at the University of Montréal.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
REGENXBIO, INC. 0.06% | 29/05/2026 | 28,861 ( 0.06% ) | 202 316 $ | 31/05/2026 |
DBV TECHNOLOGIES SA -.--% | 15/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Latest news about Daniel Tassé
Daniel Tassé active positions
| Companies | Position | Start |
|---|---|---|
| REGENXBIO INC. | Director/Board Member | 15/08/2016 |
| DBV TECHNOLOGIES | Chief Executive Officer | 29/11/2018 |
BioQ Pharma, Inc.
 BioQ Pharma, Inc. Medical SpecialtiesHealth Technology Designs and develops drug delivery systems for healthcare community | Director/Board Member | 01/12/2014 |
Roundtable On Critical Care Policy | Director/Board Member | - |
Former positions of Daniel Tassé
| Companies | Position | End |
|---|---|---|
Indivior Ltd.
 Indivior Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical drugs | Chairman | 19/11/2020 |
| BELLEROPHON THERAPEUTICS, INC. | Chief Executive Officer | 01/06/2014 |
| HLS THERAPEUTICS INC. | Director/Board Member | 01/03/2019 |
Alcresta Therapeutics, Inc.
 Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops enzyme-based products that deliver enzymatic solutions to those living with rare diseases | Chief Executive Officer | 01/11/2018 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Director/Board Member | 01/06/2015 |
Training of Daniel Tassé
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
67
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
Baxter International, Inc.
 Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
BioQ Pharma, Inc.
BioQ Pharma, Inc. Medical SpecialtiesHealth Technology Designs and develops drug delivery systems for healthcare community | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Ikaria, Inc.
 Ikaria, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics | Health Technology |
REGENXBIO, Inc.
 REGENXBIO, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy | Health Technology |
Bellerophon Therapeutics, Inc.
 Bellerophon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products to treat cardiopulmonary diseases | Health Technology |
Indivior Ltd.
Indivior Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical drugs | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Montréal
 University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DBV Technologies SA
 DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Healthcare Leadership Council
 Healthcare Leadership Council Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
NRG Energy Ltd.
 NRG Energy Ltd. Food RetailRetail Trade Retails food products | Retail Trade |
Alcresta Therapeutics, Inc.
Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops enzyme-based products that deliver enzymatic solutions to those living with rare diseases | Health Technology |
Roundtable On Critical Care Policy | |
HLS Therapeutics, Inc.
 HLS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Daniel Tassé
